Tweets
Out work showing JIA pts with sharp decline in needing TKAs, however increased TKA utilizations for tumors!! We are treating inflammatory arthritis better over timein the pediatric population...Natiowide data over 15 years! #ACR22 @Rheumnow abst# 0843 https://t.co/inw41Y1o9r
Bella Mehta @bella_mehta ( View Tweet )
3 years 8 months ago
TONIGHT! Join us! #ACR22
https://t.co/P0HHEl19hH https://t.co/zjfoNrlYGk
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
One of my personal highlights. History lesson with intersection of medicine. The hilarious @adamjbrown
@RheumNow #ACR22 #rheuminations #factsperminute https://t.co/vDoKLsVfhB
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
Abst0327 #ACR22 SMART-SLE Monitoring
Some SLE patients with +dsDNA have persistent positivity, others have fluctuations
Anti-dsDNA in persistently positive HR 1.56 for flare risk
Change (up or down!) in dsDNA more than 2x prior visit for fluctuating patients: HR 1.43
@RheumNow https://t.co/YwDPTYWPLu
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Abst0324 #ACR22
How close are we to measuring Interferon Signature in clinical practice?
NCounter and BioFire assays studied - correlated well we each other
Genes: IFI27, IFI44L, IFIT1, RSAD2
SLE higher than RA or FMS, but does not correlate with SLE activity
@RheumNow https://t.co/izpFtj9Pcd
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Abst0326 #ACR22 Anti-Mitochondrial Ab in SLE
Whole mitochondrial (AwMA), AmtDNA or AmtRNA - higher in SLE compared to controls
AwMA predictive of death, AmtDNA and AmtRNA predictive of nephritis
@Rheumnow https://t.co/d98HSHnJVE
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Abst0328 #ACR22. Predicting UCTD to CTD Meta-Analysis
Factors for SLE transition: younger age, serositis, dsDNA
SSc transition: puffy finger, NFC, or SSc antibodies
No studies wo moderate or high risk of bias
Limited studies on biomarkers for SLE, need more studies
@Rheumnow https://t.co/GofGF8TkCx
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
All monster stories end with an unexpected award: A new order
@cuttingforstone at #ACR22 tells the monster story of #covid
“How will history review our story?”
The science will get an A+, but we failed to learn the lessons of history
All was predictable through history
@RheumNow
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Year in Review #ACR22
GLORIA
Low steroid usage: lower DAS28, reduced joint damage
BUT 24% increased adverse effects
@RheumNow https://t.co/vYTAhoQEqr
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Ab1012 #ACR22
@AlexisOgdie Opioid Use & Healthcare Utilization in PsA and AS
21% PsA pts on opioids, 27% AS on opioids
Opioid users - more co-morbidities, 🚬, worse disease
Tended to higher use of anti-rheumatic drugs
Higher health care utilizations, medical $$
@RheumNow
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
@RheumNow Panel felt that weight and smoking recs were adequately covered by general health recommendations
BUT, this misses a HUGE opportunity to stress that inflammatory arthritis pts have higher risks and need greater emphasis on modifiable risk factors than gen pop
#ACR22 @RheumNow
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
CASIPSA results: CT SIJ characteristics from PsA pts similar to age- and sex-matched controls, but w/ higher prevalence of erosions, found in 18% of PsA patients. Abs 1012 #ACR22 https://t.co/jdUSUoUUbf https://t.co/2NQOhncYFc
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
